Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1995;3(6):229–235. doi: 10.1155/S106474499500069X

Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting

Arlene D Bardeguez 1,2,4,✉, Thomas Denny 2,3, Paul Palumbo 2,3, Yvonne Wesley 2,3, James Oleske 2,3, Edward Connor 2,3, Gerson Weiss 1
PMCID: PMC2364442  PMID: 18476047

Abstract

Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting.

Methods: A retrospective review was carried out of the prenatal HIV-1 counseling and testing program at University Hospital, Newark, NJ (1989-1990).

Results: Sixty-seven percent (741/1,114) of the women offered HIV-1 counseling services accepted testing and 40 (40/741:5.3%) new cases were identified. Heterosexual contact was the primary exposure (17:52%) of these women, of whom 13 (73%) had negative syphilis serologies. Sixty-four percent were asymptomatic. The mean absolute CD4 lymphocyte count in seropositive women was 514 ± 305 cells/mm3 . Severe immunosuppression was seen in 7/32 (22%) patients. Seventy-three percent (24/33) depended on public-assistance programs for their health-care services.

Conclusions: A voluntary HIV-1 counseling and testing program is well accepted in the prenatal setting. It can provide early identification of asymptomatic seropositive women and infants at risk and lead to early intervention and therapy.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastian L., Bennett C. L., Adams J., Waskin H., Divine G., Edlin B. R. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr. 1993 Jun;6(6):617–623. [PubMed] [Google Scholar]
  2. Burns D. N., Landesman S., Muenz L. R., Nugent R. P., Goedert J. J., Minkoff H., Walsh J. H., Mendez H., Rubinstein A., Willoughby A. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immune Defic Syndr. 1994 Jul;7(7):718–726. [PubMed] [Google Scholar]
  3. Calvelli T., Denny T. N., Paxton H., Gelman R., Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993 Oct;14(7):702–715. doi: 10.1002/cyto.990140703. [DOI] [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Zidovudine for the prevention of HIV transmission from mother to infant. MMWR Morb Mortal Wkly Rep. 1994 Apr 29;43(16):285–287. [PubMed] [Google Scholar]
  5. Cotton D., Watts H. Management of HIV infection during pregnancy: new options, new questions. AIDS Clin Care. 1995 Jun;7(6):45-7, 49. [PubMed] [Google Scholar]
  6. Gwinn M., Pappaioanou M., George J. R., Hannon W. H., Wasser S. C., Redus M. A., Hoff R., Grady G. F., Willoughby A., Novello A. C. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA. 1991 Apr 3;265(13):1704–1708. [PubMed] [Google Scholar]
  7. Lindsay M. K. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening. Am J Obstet Gynecol. 1993 Feb;168(2):476–479. doi: 10.1016/0002-9378(93)90475-x. [DOI] [PubMed] [Google Scholar]
  8. Minkoff H., deRegt R. H., Landesman S., Schwarz R. Pneumocystis carinii pneumonia associated with acquired immunodeficiency syndrome in pregnancy: a report of three maternal deaths. Obstet Gynecol. 1986 Feb;67(2):284–287. doi: 10.1097/00006250-198602000-00024. [DOI] [PubMed] [Google Scholar]
  9. Sande M. A., Carpenter C. C., Cobbs C. G., Holmes K. K., Sanford J. P. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. JAMA. 1993 Dec 1;270(21):2583–2589. doi: 10.1001/jama.270.21.2583. [DOI] [PubMed] [Google Scholar]
  10. Selik R. M., Chu S. Y., Buehler J. W. HIV infection as leading cause of death among young adults in US cities and states. JAMA. 1993 Jun 16;269(23):2991–2994. [PubMed] [Google Scholar]
  11. Selwyn P. A., Carter R. J., Schoenbaum E. E., Robertson V. J., Klein R. S., Rogers M. F. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA. 1989 Jun 23;261(24):3567–3571. [PubMed] [Google Scholar]
  12. Shapiro C. N., Schulz S. L., Lee N. C., Dondero T. J. Review of human immunodeficiency virus infection in women in the United States. Obstet Gynecol. 1989 Nov;74(5):800–808. [PubMed] [Google Scholar]
  13. Simonds R. J., Oxtoby M. J., Caldwell M. B., Gwinn M. L., Rogers M. F. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection. JAMA. 1993 Jul 28;270(4):470–473. [PubMed] [Google Scholar]
  14. Sperling R. S., Stratton P. Treatment options for human immunodeficiency virus-infected pregnant women. Obstetric-Gynecologic Working Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Obstet Gynecol. 1992 Mar;79(3):443–448. doi: 10.1097/00006250-199203000-00024. [DOI] [PubMed] [Google Scholar]
  15. Wasser S. C., Gwinn M., Fleming P. Urban-nonurban distribution of HIV infection in childbearing women in the United States. J Acquir Immune Defic Syndr. 1993 Sep;6(9):1035–1042. [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES